About the Fagan Lab

The Fagan Lab has studied Alzheimer Disease from multiple angles for more than 20 years. Currently, Dr. Fagan and her lab members focus on fluid biomarkers of disease with a particular interest in identifying individuals with preclinical and early stage AD. To this end, Enzyme Linked Immunosorbent Assays (ELISA), bead-based immunoassays, and cutting edge single-molecule counting systems are all employed to study protein biomarkers in cerebrospinal fluid. Most recently, the Fagan Lab has also begun to study the applicability of plasma biomarkers over the full disease spectrum from Autosomal Dominant AD (ADAD) to all stages of Late Onset AD (LOAD).
> read more

About Dr. Fagan

Anne Fagan, Professor of Neurology, Biomarker Core Lead

Anne Fagan, PhD, is a Professor of Neurology at Washington University School of Medicine in St. Louis. Her research interest and expertise is in cerebrospinal fluid (CSF) biomarkers of Alzheimer Disease (AD), especially during the preclinical (asymptomatic) period. She received her BA in Psychobiology from Wellesley College in 1984, having done her undergraduate Honor’s Thesis with Dr. Howard Eichenbaum evaluating the role of the hippocampus in a rodent model of amnesia.
> read more

Our Lab Members

Learn about Fagan lab members
> read more

Contact the Fagan-Niven Lab
E-mail: fagana@wustl.edu
Phone: (314) 362-3453 – Dr. Fagan’s Office
(314) 747-8396 – Fagan Lab

> read more